Rationale: Nontuberculous mycobacteria (NTM) are a diverse group of environmental organisms that infrequently cause human disease. Understanding of the epidemiologic and clinical characteristics associated with NTM disease is needed to refine diagnostic and treatment strategies, particularly among the less commonly isolated species.
(ATS) provides diagnostic and treatment criteria (3) , but few data exist regarding the application of these guidelines and associated outcomes (7) . Moreover, previous large studies of environmental mycobacteria often lack detailed clinical data to incorporate epidemiologic findings into this discussion (8) (9) (10) . Region-specific and species-specific data that integrate microbiologic and clinical information may enhance the utility of the ATS guidelines.
In this article, we describe the epidemiology of NTM isolated in a Washington State reference laboratory between 1998 and 2011 using modern diagnostic methods and correlate these observations with clinical data to examine factors associated with colonization and disease caused by the less common NTM. Additionally, we examine features that influence treatment decisions and clinical outcomes.
Methods Study Design
We examined all cultures of NTM submitted to the Clinical Microbiology Laboratory at Harborview Medical Center, Seattle, Washington, from 1998 to 2011. This national reference laboratory receives samples from the University of Washington healthcare system and referral laboratories primarily within Washington State. We performed a retrospective data review of those patients who had been seen within the University of Washington healthcare system who had a non-Mycobacterium avium complex (non-MAC), non-Mycobacterium gordonae NTM that had appeared in 10 or more patients. Detailed records from referral institutions were not available. The institutional review board at the University of Washington approved this study.
Microbiologic Sample Processing, Culture, and Identification
Sample processing and mycobacterial cultures were performed using standard techniques (11, 12) . Mycobacterial species were identified from culture by biochemical or molecular methods, including amplification of IS6110 for Mycobacterium tuberculosis (Mtb); amplification of 16S ribosomal RNA (rRNA) for MAC; and probe hybridization for Mtb, MAC, M. gordonae, and Mycobacterium kansasii. For specimens not identified by the above techniques, the rpoB gene was amplified and sequenced, followed by 16S rRNA and hsp65 if additional differentiation was required. The 16S rRNA gene and rpoB are single-round amplifications. The hsp65 target includes nested amplifications for Mtb complex and MAC-specific primers and fluorescence resonance energy transfer probes. Mycobacterium abscessus complex includes M. abscessus ssp. abscessus, M. abscessus ssp. massiliense, and M. abscessus ssp. bolletii (formerly M. massiliense and M. bolletii). Discrimination among these subspecies by polymerase chain reaction was not adopted by the laboratory until 2012. Body site was categorized as pulmonary (including sputum, endobronchial aspirate, or lung tissue); skin and soft tissue; disseminated (including blood or bone marrow); lymph node; sterile sites (including cerebrospinal fluid, pleural fluid and tissue, visceral tissues, and bone); and other, which included stool, urine, and sites that were not specified.
Clinical Data
Demographic and clinical information, including age, sex, ethnicity, birthplace by continent if outside Washington State, bronchiectasis, and HIV serostatus was obtained from the subset of patients who were evaluated within the University of Washington health system. The geographic origin of sample isolates included in this study was determined by the location of the submitting laboratory or clinical entity and divided a priori into six regions within the state by geographic or municipal boundaries. 
Results

Identification and Microbiology
Among 100,563 specimens submitted for mycobacterial analysis from 1998 to 2011, 4,724 samples from 3,470 patients had a positive culture or polymerase chain reaction-based identification of NTM. Seventy-four of these samples were from outside Washington State and were excluded ( Figure 1 ). Identification and nomenclature of NTM evolved over the course of the study period (see Table E1 in the online supplement). NTM were isolated 2.4 times more often than Mtb. Of NTM with more than 10 isolates, Mycobacterium szulgai (64%), M. abscessus complex (55%), and Mycobacterium xenopi (50%) were most likely to have a positive smear, similar to Mtb (49%). In contrast, only 31% of MAC isolates had a positive smear (Table E2 ). The most commonly isolated species was MAC, including Mycobacterium avium and Mycobacterium intracellulare complexes (52.1%), followed by M. gordonae (16.5%), M. abscessus complex (4.4%), Mycobacterium chelonae (4.3%), Mycobacterium fortuitum (3.7%), M. kansasii (2.2%), Mycobacterium lentiflavum (1.8%), and M. xenopi (0.9%) ( Table E3 ).
Site of Isolation
For certain organisms, including Mycobacterium marinum or Mycobacterium ulcerans, and to a lesser extent M. chelonae, skin and soft tissue sources were more common than other sites (85.7% for M. marinum or M. ulcerans; 36.4% for M. chelonae). Few organisms were identified as causing disseminated disease, primarily MAC, and more rarely M. abscessus complex, Mycobacterium heckshornense, and Mycobacterium porcinum. Organisms causing invasive disease in a sterile site included MAC and M. abscessus complex, M. chelonae, M. fortuitum, and Mycobacterium mucogenicum/phocaicum. Lymphadenitis was an uncommon finding (1.7% of all NTM isolates, of which 77% were MAC) (Table E3 ).
Geography
A total of 4,650 of the NTM isolates were derived from patients within Washington State. More than 75% of these were from the Seattle area. The most frequently identified organisms (after MAC) differed slightly by region of sample derivation. M. kansasii was not found north of Seattle, whereas Mycobacterium simiae was found only in Seattle and farther north. East of the Cascade Mountains, the most common organisms isolated were M. fortuitum ORIGINAL RESEARCH followed by M. kansasii and M. gordonae ( Figure 2 ). To determine whether location of patient origin contributed to the relative frequency of organisms isolated, we reviewed demographic records for the 937 patients with clinical information available; these samples were all obtained in Seattle.
Although an individual's specific geographic exposures or duration of time spent in Washington State were rarely available, location of birth was uniformly collected at patient registration. Of the patients, 28.9% were native to Washington State, and 23.7% were born outside the United States ( Table 1 ). The most commonly isolated NTM species from patients of all regions were MAC followed by M. gordonae and M. abscessus complex (Figure 3 ).
Among the less common NTM, frequency of isolation differed slightly in those native to Washington State in comparison to those born elsewhere (Table 1 and Figure 3 ). For example, although patients native to Washington State contributed a smaller proportion (28.7%) of NTM samples than patients from the rest of the United States (47.2%), the percentage of M. kansasii isolates obtained from patients native to Washington State was equivalent to that obtained from patients from the rest of the United States (37.0%). M. xenopi was detected primarily in patients from North America, including three patients native to Washington State. Of those with M. fortuitum, a relatively high proportion were from Asia (23.5%), and of those with M. lentiflavum, a relatively high proportion were from Africa (22.6%) ( Table 1) . Together, these data suggest that NTM have specific geographic associations, including distinct patterns within Washington State, and that both place of residence and place of origin may contribute.
Risk Factors by Organism
We reviewed the charts of patients with the most common non-MAC NTM species to identify risk factors associated with isolation of specific NTM (Table 2) , chosen by those with more than 25 positive samples associated with clinical data. Patients with M. simiae were reviewed, but this group comprised only six patients.
Overall, this was a highly medically complex population, including those with M. gordonae. Among 217 patients, 83% had one or more comorbid conditions, including HIV, diabetes, lung disease, malignancy, or immunosuppression (including all but one of the patients with M. gordonae). Although HIV was relatively uncommon, the majority of CD4 counts at diagnosis of the NTM were less than 100 (median, 95; range, 2-722; n = 26). For patients with HIV infection, the median number of CD4 cells per milliliter for four patients with HIV and M. kansasii was 60 (range, 12-110); for three patients with M. lentiflavum, it was 25 (range, 14-347); and for three patients with M. xenopi, it was 128 (range, 9-221). In contrast, the median among those with M. gordonae (n = 8) was 168 (range, 3-722).
Chronic lung disease and bronchiectasis were very common, particularly among patients with M. abscessus complex, though they were absent among patients with M. xenopi. COPD was not more likely among those with M. kansasii (25.9%) than among those with any organism (25.3%). Chest imaging was infrequently normal (20%). Diffuse infiltrates were most common, followed by masses or nodules. Malignancy was most common among M. gordonae and M. xenopi, and active immunosuppression was most common among patients with M. chelonae or M. xenopi (though least common among those with M. kansasii). Homelessness and intravenous drug use were most common among patients with M. fortuitum. Finally, a history of Mtb was most common among patients with M. lentiflavum. Together, these data point out associations between specific NTM and certain clinical risk factors.
Risk Factors by Site of Isolation
Among 214 patients with one of the studied mycobacterial species, 191 were isolated from pulmonary sources, 18 from skin or soft tissue, and 5 from disseminated or sterile site infections (Table 3 ). The two sterile site infections were both vertebral osteomyelitis, one with M. fortuitum and the other with M. xenopi. One of these patients had a history of injection drug use, Table 1 .
ORIGINAL RESEARCH
and the other had post-transplant immunosuppression.
Of the three with bacteremia, one had M. porcinum associated with a central venous catheter, and the other two had M. abscessus complex that was not line associated. Among 13 patients with skin or soft tissue infections with M. chelonae, 4 were associated with a medically implanted foreign object and 1 with a surgical wound. Patients with soft tissue infections caused by NTM were more likely to be immunosuppressed (66.7% vs. 23.3%; P , 0.0001) and less likely to have pulmonary disease, though 10% still had bronchiectasis.
Clinical Characteristics Associated with Meeting ATS Criteria
To examine the distinguishing features of patients meeting ATS criteria with these less commonly isolated organisms, we analyzed a control group of patients with isolation of M. gordonae, which is generally considered to be nonpathogenic. In our sample of 121 patients with isolation of M. gordonae, only 2 were treated for invasive disease.
We selected 50 patients with pulmonary isolation of M. gordonae in the absence of other organisms and compared them with the group of patients with pulmonary isolation of non-MAC, non-M. gordonae NTM meeting ATS criteria ( Table 4 ). The M. gordonae group had a median age of 57.5 years and was more Definition of abbreviations: ATS = American Thoracic Society; COPD = chronic obstructive pulmonary disease; CXR = chest radiograph; IVDU = intravenous drug use. *The maximum number of patients with data available. † Fifty of 121 Mycobacterium gordonae patients were selected for detailed review. One was excluded after identification because of concomitant isolation of Mycobacterium hassiacum. ‡ HIV status is listed if there was documentation of testing in the clinical record, either by patient report or by test result. x Includes only patients with pulmonary samples. jj Two patients of the 121 total with M. gordonae received therapy, one with positive culture of a lung biopsy specimen and the second by bronchoalveolar lavage. The latter initially had some improvement with therapy; however, neither had long-term improvement in their symptoms. These two patients were not included among those selected for detailed review. ¶ Deaths of M. gordonae patients are not listed, because these were extracted after the close of the study period.
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likely than the non-M. gordonae group to have a major medical condition (97.9% vs. 75.0%; P = 0.001). In comparison, the non-M. gordonae group was slightly younger (median age, 49.5 yr; P = 0.04), more likely to have bronchiectasis (62.5% vs. 27.1%; P , 0.0001), and more likely to have abnormal chest imaging (94.6% vs. 71.4%; P = 0.005). Only 20% of those with M. gordonae met ATS criteria by the same metric; they were much less likely to have multiple positive cultures (82.1% vs. 14.6%; P , 0.0001).
Of note, 33.3% of non-M. gordonae patients meeting ATS criteria had an alternative diagnosis to account for their presentation, whereas 93.3% of patients with M. gordonae did (P , 0.0001). Excluding non-M. gordonae patients with alternative diagnoses did not alter the statistical results (data not shown).
Outcomes
Among patients with pulmonary isolates, those with M. abscessus complex and M. kansasii were most likely to be treated, although those with M. porcinum and M. xenopi more often met ATS criteria. Of the 56 patients who met ATS criteria for NTM lung disease, 22 were treated (Table 4 ). Of the 22 treated patients, 19 had M. abscessus complex (13) or M. kansasii (5). Of those who were not treated, 17 had an alternative diagnosis, including bacterial pneumonia or CF exacerbation (4), MAC (4), Pneumocystis (2), malignancy, tuberculosis, Nocardia, and sarcoidosis. In the remaining 17, cultures were reviewed and the organism was not thought to be pathogenic (7) , review of the cultures was not documented (3), the patients were lost to follow-up (4), or there was insufficient information (3) .
Some patients with pulmonary isolation of NTM were treated without meeting ATS criteria, including five with M. abscessus complex, two with M. simiae, two with M. fortuitum, and one each with M. kansasii and M. chelonae. Four of five patients with sterile site or disseminated infection were treated with antibiotics; one case of bacteremia was discovered after the patient's death. Finally, of the patients with skin and soft tissue isolation of NTM, 68.4% were treated.
Among patients with pulmonary isolates, the proportion of patients who died within the study period was the same as in those who did or did not receive therapy (33.7% vs. 34.6%; P = 0.9). This remained true when we included only those who met ATS criteria (42.9% with therapy vs. 35.3% without; P = 0.5) and those without definitive alternative diagnoses (40.9% vs. 37.5%; P = 0.8). Among those with skin and soft tissue isolation of NTM, the majority of the patients were deceased at the end of the study period (53.3%), in comparison to only one of three patients with bacteremia (a patient with M. abscessus complex). Table 5 lists the treatment regimens of the patients treated for each organism (including all sites of isolation). In general, these regimens tended to follow ATS recommendations. For example, a macrolide-based regimen for treatment of M. abscessus complex was used in 17 of 19 patients, and treatment of M. kansasii was composed of rifampin, ethambutol, and isoniazid in 5 of 6 patients, though providers added pyrazinamide in 3 patients. Together, these data suggest that clinicians rely upon published guidelines once a decision to treat has been made. In contrast, the decision to treat is variable, especially for the less wellunderstood species.
Treatment Regimens
Discussion
In our present study, we examined the clinical and epidemiologic factors (6, 9, 14) . To our knowledge, this is the largest study with detailed clinical data and the only such study done in Washington State. Previous studies in the United States suggest that some NTM are geographically restricted. In the United States, M. kansasii has appeared to originate primarily in the Midwest, the South, and California (9, 13, 14) . Furthermore, M. kansasii and M. lentiflavum were rarely isolated in a large series in Oregon, which directly neighbors Washington State (9) .
The higher frequency of M. kansasii isolated in our series may be due to specific geographic features of Washington State, a changing environment, or increasing globalization and travel. We also observed other geographic differences, including rare isolation of Mycobacterium scrofulaceum and absence of M. malmoense, which have been reported more frequently elsewhere (15, 16) . In contrast to previously published data estimating that M. xenopi represents about 12% of isolates from North America (15), we found few patients with M. xenopi (0.9% of all isolates), similar to data from Oregon (0.3%) (9) .
When we analyzed the location of patient birth and the source of sample collection (Figures 2 and 3) , the most commonly isolated NTM species in each category was MAC, followed by M. gordonae and M. abscessus complex. The exceptions were those who were born in Africa, in whom M. lentiflavum was more common than M. abscessus complex, and those with isolates obtained east of the Cascade Mountains or north of Seattle, in whom M. fortuitum was second and third most common, respectively.
Additional microvariation was observed within Washington State, though the comparison was limited by few patients in certain regions, including that M. abscessus complex and M. lentiflavum were not isolated from samples from the Olympic Peninsula or east of the Cascade Mountains. Likewise, M. kansasii was not isolated from samples from the Olympic Peninsula or north of Seattle. The organisms that were isolated from patients on the peninsula included M. mucogenicum/ phocaicum, Mycobacterium paraffinicum, and Mycobacterium nebraskense/seolense, entities that were less common elsewhere. These observations may reflect regional variation in climate or immigration patterns. To our knowledge, this is the first study to demonstrate NTM heterogeneity based on both regional microvariation and the patient's location of origin.
We identified several host factors associated with susceptibility to colonization or disease with specific NTM, and for pulmonary isolates, we used M. gordonae to place those in context of patients with NTM colonization. Overall, 
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the patients with NTM colonization and disease were medically complex. Of 50 patients with pulmonary isolation of M. gordonae, 49 had a major comorbid condition and more than 70% of these had abnormal chest imaging, though none of these patients were thought to have mycobacterial disease. As previously described, M. abscessus complex was associated with CF, diabetes, and bronchiectasis (17) (18) (19) ; the high prevalence of CF was not seen in other NTM. Among 10 individuals with M. xenopi, 4 of 8 pulmonary cases met ATS criteria, similar to rates seen in European studies (20, 21) . In contrast to previous studies, none of the patients with M. xenopi had chronic lung disease, though all were relatively immunocompromised via either transplant, malignancy, or HIV (20, 22) . Although M. kansasii has tended to be associated with COPD (3), the proportion of patients with COPD was similar among those with M. kansasii in comparison to other organisms. These data highlight associations of clinical risk factors with specific NTM as well as instances where risk factors or clinical course differ from that described in other regions.
The mortality in this group of patients over the study period was high: 38% of all reviewed patients, 41.5% of those with pulmonary isolates, 41.5% of those with pulmonary isolation meeting ATS criteria, and 53.3% of those with skin and soft tissue infection. We suspect that the higher mortality seen in the group with soft tissue infection reflects the increased severity of the accompanying comorbidities (66.7% vs. 22.3% on immunosuppressive medication; 38.9% vs. 19.3% with diabetes). Consistent with this observation, both patients with vertebral osteomyelitis died within the study period, whereas only one of three with a bacteremia did.
Very few deaths among patients with pulmonary isolates were thought to be related to mycobacterial infection, and all of those were due to M. abscessus complex. Treatment was not associated with a difference in mortality, including among those meeting ATS criteria and those without alternative diagnoses.
Limitations
This study has several limitations, including a retrospective study design and a small sample size for these uncommon organisms. Our population was unique in a few ways. First, males were overrepresented on the whole (62.1%) as well as among sujbects with individual mycobacteria, with the exception of M. porcinum. This differs from many other large American studies in which researchers have reported a female predominance (5, 6, 23) . It is not reflective of a male predominance in our medical record system, however, where the ratio of male to female patients is 0.92.
There was a high prevalence of medical comorbidities, including CF, which may reflect the University of Washington's position as a tertiary referral center. Interestingly, a substantial number of subjects had a history of tuberculosis (10.2%) or active disease (3.7%). The frequency of cultures positive for M. tuberculosis among the submitted samples (2.4% of all acid-fast bacilli cultures in our study) was similar to that of previous studies (1 to 2%) (24) (25) (26) . We are not aware of reports of the prevalence of tuberculosis in patients with NTM, so it is unclear whether our findings are representative.
Our data suggest that both location of residence and location of birth may contribute to colonization by certain NTM, but we were unable to compile information on duration of residency. We also observed that certain NTM were rarely treated and that treatment did not influence mortality, but we do not have a sufficient number of cases to compare outcomes with regard to therapy by each organism. Finally, although we assessed treatment decisions and mortality, we were unable to evaluate morbidity, which may be an important feature of infection or colonization with NTM.
Conclusions
Our study demonstrates that NTM in Washington State have specific associations with geographic regions, clinical risk factors, and treatment decisions. Among *Indicates the number of patients for whom there is treatment regimen data available. These patients include those with any site of infection, including pulmonary, skin and soft tissue, and disseminated or sterile site disease. † Tetracycline also includes doxycycline or minocycline. ‡ Three additional patients underwent removal of the involved foreign body without use of antimicrobials.
x One patient was also treated with trimethoprim/sulfamethoxazole.
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patients with pulmonary isolates, even patients with colonization were medically complicated. The clinician's decision to pursue therapy was likewise complex, and although treatment was given primarily for patients with M. abscessus complex and M. kansasii, among those with other organisms, treatment did not significantly alter mortality. Many of these findings differ from those of previously published regional reports and underscore the heterogeneity associated within this genus of organisms as well as the value in compiling location-based information. n Author disclosures are available with the text of this article at www.atsjournals.org.
